All News

Orthofix International Reports Fourth Quarter and Fiscal 2014 Financial Results

LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix International N.V. (NASDAQ:OFIX) (the “Company,” “we,” “us” or “our”), a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets, today reported its financial results

DJO Global, Inc. Announces Early Tender Results for the Exchange Offer and Consent Solicitation with Respect to Senior Subordinated Notes

SAN DIEGO–(BUSINESS WIRE)–DJO Global Inc. (“DJO” or the “Company”), a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced the results, as of 5:00 p.m., New York City time, on April 29,

Impaired Muscle Mitochondrial Biogenesis, Myogenesis Behind Spinal Muscular Atrophy – See more at: http://www.hcplive.com/journals/internal-medicine-world-report/2015/April-2015/Impaired-Muscle-Mitochondrial-Biogenesis-Myogenesis-Behind-Spinal-Muscular-Atrophy-#sthash.OCewnb6j.dpuf

By Jackie Syrop Research, led by Michela Ripolone, PhD, Centro Dino Ferrari, Universita degli Studi Milano, concluded that an altered regulation of myogenesis and a downregulated mitochondrial biogenesis contribute to pathologic changes in the muscle o…

Cory Hahn serving as ambassador for spinal cord research

Former Arizona State baseball player Cory Hahn is continuing his mission to aid spinal cord research by participating for a second time in the Red Bull Wings for Life World Run on Sunday, May 3, in Santa Clarita, Calif. Hahn, now

BONESUPPORT Announces CE-Mark of CERAMENT™|V, the First Injectable Vancomycin Eluting Bone Substitute in the Management of Osteomyelitis

LUND, Sweden, April 29, 2015 /PRNewswire/ — BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced that it has received CE-mark for CERAMENT™|V, the first injectable vancomycin eluting bone substitute indicated

UW surgeon, 74, bound for Nepal to aid earthquake victims

By JoNel Aleccia A 74-year-old orthopedic surgeon and spine specialist from Seattle is among a crew of emergency-medical workers heading to Nepal in the wake of Saturday’s devastating 7.8-magnitude earthquake that has left more than 4,700 dead and 8,000 injured.

SpineFrontier Accused of Violating False Claims Act by Whistleblower

Device Maker Accused Of Firing Accountant Over FCA Claims By Jacob Fischler Law360, Washington (April 28, 2015, 6:48 PM ET) — A former accountant at a medical device company said in a three-count complaint in Massachusetts federal court Tuesday she was

Should Younger Patients Ever Have Knee Replacement Surgery?

By Christin Melton The Treatment of Choice for Younger Patients Jack M. Bert, MD, an orthopedic surgeon at Minnesota Bone & Joint Specialists in Woodbury, Minnesota, has an important message for his colleagues: Always choose a high tibial osteotomy (HTO)

UI orthopedics researchers working on injectable, bioactive gel that can repair cartilage damage

Knee injuries are the bane of athletes everywhere, from professionals and college stars to weekend warriors. Current surgical options for repairing damaged cartilage caused by knee injuries are costly, can have complications, and often are not very eff…

CyMedica Orthopedics Launches The QB1 System – A Proprietary Device For Treatment Of Quadriceps Atrophy – At AANA

SCOTTSDALE, Ariz., April 29, 2015 /PRNewswire/ — Scottsdale-based CyMedica Orthopedics™, Inc. announced the commercial launch of the CyMedica QB1™ System for the treatment of quadriceps muscle atrophy at the Arthroscopy Association of North American Arthroscopic Society for Sports Medicine (AANA) annual meeting in Los

© 2019 MedDeviceJobs.com Powered by Careerleaf
v.3.1.4-1-gadb0b06